Clinical Trial Update: Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing misoprostol for treating postpartum hemorrhage has completed, including evaluation of fever as a safety outcome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Postpartum Hemorrhage | Phase 3 | Status: COMPLETED